| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of the European Academy of Dermatology and Venereology |
| Vol/bind | 36 |
| Udgave nummer | 5 |
| Sider (fra-til) | e389-e392 |
| ISSN | 0926-9959 |
| DOI | |
| Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:Medical writing services were provided by Samantha D. Francis Stuart, PhD, and Joann Hettasch, PhD, of Fishawack Facilitate Ltd, part of Fishawack Health, and funded by AbbVie. The patients in this study have given written informed consent to the publication of their case details.
Funding Information:
has received fees for speaking and consultancy from Pfizer, AbbVie, Amgen, Forward Pharma, UCB, Gilead, Biogen, BMS, MSD, Novartis, Eli Lilly and Janssen Pharmaceuticals and research grants from Novartis, UCB, Eli Lilly and Pfizer. has received honoraria or fees for serving on advisory boards, or as a speaker, or as a consultant and grants as an investigator from AbbVie, Amgen, Astellas, Baxalta, Baxter, Boehringer Ingelheim, Bristol‐Myers Squibb, Celgene, Coherus, Dermira, Eli Lilly, Forward Pharma, Galderma, Genentech, GlaxoSmithKline, Janssen, Kyowa‐Hakko Kirin, LEO Pharma, MedImmune, Merck‐Serono, Merck Sharp & Dohme, Novartis, Pfizer, Regeneron, Roche, Sanofi‐Genzyme, Stiefel, Sun Pharma, Takeda, UCB and Valeant. . is a consultant and/or investigator for Amgen, Bristol‐Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, Sun Pharma, Biogen, Pfizer and Leo Pharma. has received grants from AbbVie, Pfizer, Roche, Chugai, GSK and Janssen, and consultant, speaker or advisory board fees from Amgen, AbbVie, Pfizer, Roche, Chugai, UCB, BMS, Celgene, MSD, Novartis, Biotest, Janssen, Genzyme, Lilly, Boehringer and Sandoz. . and are full‐time employees of AbbVie and may hold AbbVie stock and/or stock options. L.E. Kristensen K. Papp J.F Merola F. Behrens A.M. Soliman, L Barcomb, Z. Wang A. Eldred